← Back to Search

NEURESCUE device for Cardiac Arrest (ARISE Trial)

N/A

Recruiting

Led By David Shavelle, M.D.

Research Sponsored by neurescue

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed up to 10 min

Awards & highlights

ARISE Trial Summary

This trial will show whether the NEURESCUE device, which is inserted through the femoral artery, can improve blood flow to the heart and brain in adults experiencing cardiac arrest.

Eligible Conditions

Cardiac Arrest
Cardiovascular Disease

ARISE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed up to 10 min

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed up to 10 min

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed up to 10 min for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Successful balloon inflation within 10 minutes from first vessel puncture

Secondary outcome measures

Change in central blood pressure

Rate of occlusion success

Return of spontaneous circulation (ROSC)

+2 more

ARISE Trial Design

1Treatment groups

Experimental Treatment

Group I: TreatmentExperimental Treatment1 Intervention

The NEURESCUE device will be used as an adjunct to ACLS.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

NEURESCUE device

2022

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

neurescueLead Sponsor

2 Previous Clinical Trials

10 Total Patients Enrolled

2 Trials studying Cardiac Arrest

10 Patients Enrolled for Cardiac Arrest

David Shavelle, M.D.Principal InvestigatorLong Beach Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current vacancies for willing participants in this trial?

"According to the latest information available on clinicaltrials.gov, this study is not recruiting patients at this time. This trial was first posted on July 1st, 2022 and was last updated on June 29th, 2022. There are other 499 trials that are open for recruitment."

Answered by AI

Would this test be appropriate for someone who is over 30 years old?

"Individuals aged 18-70 who meet the other inclusion criteria laid out by the study may participate. There are currently 36 trials recruiting patients under 18 and 449 for people over 65."

Answered by AI

Are there restrictions on who is able to enroll in this clinical trial?

"Up to 10 individuals that have had a cardiac arrest and are aged between 18 and 70 years old may participate in this trial. To be eligible, patients must meet the following conditions: they must have received CPR within 7 minutes of the presumed arrest, and have had 8 minutes of continuous ACLS without ROSC."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

2022. "NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05444049.

All > Cardiac Arrest